$GTCH Danny Rittman, CTO of GBT Technologies Inc. (OTC

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
126
$GTCH Danny Rittman, CTO of GBT Technologies Inc. (OTC Pink: GTCH), the company elected to release the first version of its AI-powered human vitals device, qTerm with only three of the four originally-planned features included. He explained that this was a decision made to meet the demand brought on by the COVID-19 pandemic.

"Originally, the qTerm device was planned to come out in its first release with four features - body temperature, heart rate, blood pressure and oxygen," he said. "Due to the pandemic, we wanted to push it out faster [to get] something to the market to help with the [COVID-19] virus."

This first release will feature the ability to easily measure body temperature, blood oxygen level and heart rate - measurements indicative of COVID-19 infection. Rittman explained that this data, with consent from the user, can be aggregated and put toward a worldwide 'thermal map' to alert others about potential health risks.

"This data … will be fed through the medical app to a backend program, which is where we're going to do processing, analytics and with the user's permission, we'll keep their location in," he said. "It can still be anonymous but we'll be able to alert users about "hot zones" that have people with symptoms and that could be a health risk."

In a recent press release explaining the qTerm's completed features, Rittman indicated that GBT planned "to expand the device further in the future, adding more features and AI capabilities."

"On the second release we're going to add the blood pressure feature as well," he said.

Elsewhere, it was announced that GBT Technologies has received a notice of allowance from the United States Patent and Trademark Office for its 3D, Monolithic, multi-dimensional, multi-plane, memory structure for integrated circuits patent. Rittman described the current state of integrated circuit (IC) design, and how this new patent will upgrade and enhance the technology, affording greater capabilities.

"The 3D monolithic chip patent is dealing with a new way to fabricate microchips and silicon," he said. "Today the silicon is a flat surface, and we basically build, - in layman's terms - create, or etch the chip on top of the silicon. So, we still have a flat surface, it's one plane and it's limited."

"Our patent, on that level, is actually taking this and making a new paradigm," he said. "Image it as multi-planar, so it's not just a flat surface. I can make it, for example, as a honeycomb shape where the honeycombs, or hexagons, have many additional planes to place the transistor on them. The shifting from the single plane surface to a multi-planar three-dimensional surface will significantly increase the number of transistors and the amount of circuitry that can be placed on the chip."

This multidimensional design, by increasing the silicon surface for transistors, could significantly improve the memory and functionality of microchips.

"With more area you can have a larger memory," he said. "A single chip can include terabytes instead of gigabytes, as we have today."

Rittman said in the attendant press release:

"We intend to explore various practical uses for this technology including with memory cells, micro solar cells and MEMS chips, we believe enabling larger silicon areas will create new horizons for the creation of advanced, miniaturized electro-mechanical systems like micro-sensors and micro-actuators with the goal of creating advanced AI, CPU and powerful GPUs within smaller areas."

"We predict that this is going to take some time before it comes into effect since it's an advanced task, making fabrication equipment for multi-planar chips, but this is definitely the future," he said.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading